A new ai drug-discovery engine has been developed, with some reports suggesting it is on the scale of an AlphaFold4. The engine is associated with Isomorphic Labs, which has received significant funding, reportedly $2.1 billion, to scale its ai-driven drug discovery efforts. The development may have implications for the field of drug discovery, potentially offering alternatives to traditional methods such as animal testing.